FORSYTH DOUGLAS bought INBX

September 8, 2026 · Form 4 insider transaction

FORSYTH DOUGLAS bought 2,500 shares of Inhibrx Biosciences, Inc. at $114.65 per share, a transaction worth $286.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,500
Price
$114.65
Total value
$286.6K
Role
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 8, 2026
Filing dateSeptember 8, 2026
Shares owned after227,064
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The shares were purchased in multiple transactions at prices ranging from $114.36 to $114.689 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.; The reporting person is a trustee of the Forsyth Family Trust Dated July 20, 2001 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Forsyth Family Trust Dated July 20, 2001.

View the original Form 4 on SEC EDGAR